Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia

It was recently recognized that some chronic myeloid leukemia patients with a complete molecular response could sustain that response after discontinuation of imatinib. To characterize the clinical outcomes and profiles of chronic phase chronic myeloid leukemia patients who could discontinue imatini...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Takahashi, Naoto, Kyo, Taiichi, Maeda, Yasuhiro, Sugihara, Takashi, Usuki, Kensuke, Kawaguchi, Tatsuya, Usui, Noriko, Okamoto, Shinichiro, Ohe, Yokiko, Ohtake, Shigeki, Kitamura, Kunio, Yamamoto, Masahide, Teshima, Hirofumi, Motoji, Toshiko, Tamaki, Toshiharu, Sawada, Kenichi, Ohyashiki, Kazuma
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ferrata Storti Foundation 2012
Ämnen:
Original Articles and Brief Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366657/
https://ncbi.nlm.nih.gov/pubmed/22180435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.056853
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk